M. Stojanovic
Impact in
-
- Multiple Sclerosis Research Studies
- Neurology top 5%
- Peripheral Neuropathies and Disorders
Papers in
-
- Multiple Sclerosis Research Studies 9
-
- Hereditary Neurological Disorders 4
- Co-authors
- Gavin Giovannoni (9 shared papers)Krzysztof Selmaj (10 shared papers)Stephen Lake (9 shared papers)Alasdair Coles (10 shared papers)Douglas L. Arnold (10 shared papers)David Margolin (10 shared papers)Vesna Brinar (10 shared papers)Eva Havrdová (10 shared papers)
- Journals
- Neurology (6 papers)Journal of the Peripheral Nervous System (3 papers)Journal of the Neurological Sciences (3 papers)Journal of Neurology (2 papers)The Lancet (1 paper)
- Partner nations
- SerbiaUnited KingdomCroatia
In The Last Decade
M. Stojanovic
18 papers receiving 1.0k citations
M. Stojanovic's Hit Papers
Peers
Comparison fields: 5 of 70
- Pathology and Forensic Medicine 773
- Neurology 243
- Rheumatology 131
- Immunology 185
- Developmental Neuroscience 29
Countries citing papers authored by M. Stojanovic
This map shows the geographic impact of M. Stojanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Stojanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Stojanovic more than expected).
Fields of papers citing papers by M. Stojanovic
This network shows the impact of papers produced by M. Stojanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Stojanovic. The network helps show where M. Stojanovic may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Stojanovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial Hit paper breakdown → | 2012 | 892 |
| 2 | 2016 | 28 | |
| 3 | 2017 | 27 | |
| 4 | 2018 | 17 | |
| 5 | 2020 | 11 | |
| 6 | 1989 | 9 | |
| 7 | 2020 | 8 | |
| 8 | 2013 | 7 | |
| 9 | 2013 | 6 | |
| 10 | 2013 | 5 | |
| 11 | 2012 | 5 | |
| 12 | 2012 | 5 | |
| 13 | 2018 | 4 | |
| 14 | 2012 | 4 | |
| 15 | 2012 | 3 | |
| 16 | 2012 | 3 | |
| 17 | 2012 | 2 | |
| 18 | 2016 | 1 |
About M. Stojanovic
M. Stojanovic is a scholar working on Pathology and Forensic Medicine, Cellular and Molecular Neuroscience, Neurology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 18 papers that have together received 1.0k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (9 papers), Peripheral Neuropathies and Disorders (5 papers), Hereditary Neurological Disorders (4 papers), Immunotherapy and Immune Responses (3 papers), Peripheral Nerve Disorders (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Long-Term Effects of COVID-19 (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (773 citations), Neurology (243 citations), Rheumatology (131 citations), Immunology (185 citations) and Developmental Neuroscience (29 citations). M. Stojanovic has collaborated with scholars based in Serbia, United Kingdom and Croatia. Frequent co-authors include Gavin Giovannoni, Krzysztof Selmaj, Stephen Lake, Alasdair Coles, Douglas L. Arnold, David Margolin, Vesna Brinar, Eva Havrdová, Elizabeth Fisher and Howard L. Weiner. Their work appears in journals such as Neurology, Journal of the Peripheral Nervous System, Journal of the Neurological Sciences, Journal of Neurology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.